Antallet af SREs var desuden signifikant reduceret ved Bondronat 6 mg ligesom der var en 40% reduktion i risiko for en SRE i forhold til placebo (relativ risiko 0, 6, p=0, 003).
The number of SREs was also significantly reduced with Bondronat 6 mg and there was a 40% reduction in the risk of a SRE over placebo (relative risk 0.6, p = 0.003).